Skip to main content

Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Volume 9, Number 10, 1 October 2011

Free Content Racial differences in venous thromboembolism
pp. 1877-1882(6)
Authors: ZAKAI, N. A.; McCLURE, L. A.

Favourites:
ADD

Free Content Combined influence of proton‐pump inhibitors, calcium‐channel blockers and CYP2C19*2 on on‐treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention
pp. 1892-1901(10)
Authors: HARMSZE, A. M.; VAN WERKUM, J. W.; SOUVEREIN, P. C.; BREET, N. J.; BOUMAN, H. J.; HACKENG, C. M.; RUVEN, H. J. T.; TEN BERG, J. M.; KLUNGEL, O. H.; DE BOER, A.; DENEER, V. H. M.

Favourites:
ADD

Free Content Low‐molecular‐weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST‐elevation myocardial infarction: a meta‐analysis
pp. 1902-1915(14)
Authors: NAVARESE, E. P.; DE LUCA, G.; CASTRIOTA, F.; KOZINSKI, M.; GURBEL, P.A.; GIBSON, C. M.; ANDREOTTI, F.; BUFFON, A.; SILLER‐MATULA, J. M.; SUKIENNIK, A.; DE SERVI, S.; KUBICA, J.

Favourites:
ADD

Free Content Comparison of two prognostic models for acute pulmonary embolism: clinical vs. right ventricular dysfunction‐guided approach
pp. 1916-1923(8)
Authors: VANNI, S.; NAZERIAN, P.; PEPE, G.; BAIONI, M.; Risso, M.; GRIFONI, G.; VIVIANI, G.; GRIFONI, S.

Favourites:
ADD

Free Content Treatment of upper‐extremity deep vein thrombosis
pp. 1924-1930(7)
Authors: RATHBUN, S. W.; STONER, J. A.; WHITSETT, T. L.

Favourites:
ADD
Favourites:
ADD

Free Content Evidence for heterogeneity of the obstetric antiphospholipid syndrome: thrombosis can be critical for antiphospholipid‐induced pregnancy loss
pp. 1937-1947(11)
Authors: POINDRON, V.; BERAT, R.; KNAPP, A. M.; TOTI, F.; ZOBAIRI, F.; KORGANOW, A. S.; CHENARD, M. P.; GOUNOU, C.; PASQUALI, J. L.; BRISSON, A.; MARTIN, T.

Favourites:
ADD

Free Content Surgery and inhibitor development in hemophilia A: a systematic review
pp. 1948-1958(11)
Authors: ECKHARDT, C. L.; van der BOM, J. G.; VAN DER NAALD, M.; PETERS, M.; KAMPHUISEN, P. W.; FIJNVANDRAAT, K.

Favourites:
ADD

Free Content Activation of hemostasis in brain dead organ donors: an observational study
pp. 1959-1965(7)
Authors: LISMAN, T.; LEUVENINK, H. G. D.; PORTE, R. J.; PLOEG, R. J.

Favourites:
ADD
Favourites:
ADD

Free Content Mutations in disguise
pp. 1973-1976(4)
Authors: DUGA, S.; ASSELTA, R.

Favourites:
ADD

Free Content Point mutations regarded as missense mutations cause splicing defects in the factor XI gene
pp. 1977-1984(8)
Authors: ZUCKER, M.; ROSENBERG, N.; PERETZ, H.; GREEN, D.; BAUDUER, F.; ZIVELIN, A.; SELIGSOHN, U.

Favourites:
ADD

Free Content Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome
pp. 1985-1992(8)
Authors: TERUEL, R.; PÉREZ‐SÁNCHEZ, C.; CORRAL, J.; HERRANZ, M. T.; PÉREZ‐ANDREU, V.; SAIZ, E.; GARCÍA‐BARBERÁ, N.; MARTÍNEZ‐MARTÍNEZ, I.; ROLDÁN, V.; VICENTE, V.; LÓPEZ‐PEDRERA, C.; MARTÍNEZ, C.

Favourites:
ADD

Free Content Validation of an automated latex particle–enhanced immunoturbidimetric von Willebrand factor activity assay
pp. 1993-2002(10)
Authors: CHEN, D.; TANGE, J. I.; MEYERS, B. J.; PRUTHI, R. K.; NICHOLS, W. L.; HEIT, J. A.

Favourites:
ADD

Free Content The factor VIII inhibitor assays can be standardized: results of a workshop
pp. 2003-2008(6)
Authors: VERBRUGGEN, B.; DARDIKH, M.; POLENEWEN, R.; VAN DUREN, C.; MEIJER, P.

Favourites:
ADD

Free Content Muscle‐directed gene therapy for hemophilia B with more efficient and less immunogenic AAV vectors
pp. 2009-2019(11)
Authors: WANG, L.; LOUBOUTIN, J.‐P.; BELL, P.; GREIG, J. A.; LI, Y.; WU, D.; WILSON, J. M.

Favourites:
ADD

Free Content Plasminogen activator inhibitor type I contributes to protective immunity during experimental Gram‐negative sepsis (melioidosis)
pp. 2020-2028(9)
Authors: KAGER, L. M.; WIERSINGA, W. J.; ROELOFS, J. J. T. H.; MEIJERS, J. C. M.; LEVI, M.; Van'T VEER, C.; van der POLL, T.

Favourites:
ADD

Free Content A novel automated microchip flow‐chamber system to quantitatively evaluate thrombus formation and antithrombotic agents under blood flow conditions
pp. 2029-2037(9)
Authors: HOSOKAWA, K.; OHNISHI, T.; KONDO, T.; FUKASAWA, M.; KOIDE, T.; MARUYAMA, I.; TANAKA, K. A.

Favourites:
ADD

Free Content Streptococcus sanguinis‐induced cytokine release from platelets
pp. 2038-2049(12)
Authors: MCNICOL, A.; AGPALZA, A.; JACKSON, E. C. G.; HAMZEH‐COGNASSE, H.; GARRAUD, O.; COGNASSE, F.

Favourites:
ADD

Free Content Aspirin has little additional anti‐platelet effect in healthy volunteers receiving prasugrel
pp. 2050-2056(7)
Authors: LEADBEATER, P. D. M.; KIRKBY, N. S.; THOMAS, S.; DHANJI, A.‐R.; TUCKER, A. T.; MILNE, G. L.; MITCHELL, J. A.; WARNER, T. D.

Favourites:
ADD

Free Content Involvement of circulating platelets on the hyperalgesic response evoked by carrageenan and
pp. 2057-2066(10)
Authors: YAMASHITA, K. M.; NOGUEIRA, T. O.; SENISE, L. V.; CIRILLO, M. C.; GONÇALVES, L. R. C.; SANO‐MARTINS, I. S.; GIORGI, R.; SANTORO, M. L.

Favourites:
ADD

Free Content The Syk‐kinase inhibitor R406 impairs platelet activation and monocyte tissue factor expression triggered by heparin‐PF4 complex directed antibodies
pp. 2067-2076(10)
Authors: LHERMUSIER, T.; VAN ROTTEM, J.; GARCIA, C.; XUEREB, J.‐M.; RAGAB, A.; MARTIN, V.; GRATACAP, M.‐P.; SIÉ, P.; PAYRASTRE, B.

Favourites:
ADD

Free Content Relative contributions of stromal interaction molecule 1 and CalDAG‐GEFI to calcium‐dependent platelet activation and thrombosis
pp. 2077-2086(10)
Authors: AHMAD, F.; BOULAFTALI, Y.; GREENE, T. K.; OUELLETTE, T. D.; PONCZ, M.; FESKE, S.; BERGMEIER, W.

Favourites:
ADD

Free Content Splice variants of tissue factor promote monocyte‐endothelial interactions by triggering the expression of cell adhesion molecules via integrin‐mediated signaling
pp. 2087-2096(10)
Authors: SRINIVASAN, R.; OZHEGOV, E.; VAN DEN BERG, Y. W.; ARONOW, B. J.; FRANCO, R. S.; PALASCAK, M. B.; FALLON, J. T.; RUF, W.; VERSTEEG, H.H.; BOGDANOV, V.Y.

Favourites:
ADD

Free Content An international collaborative study to establish the WHO 1st international standards for C1‐inhibitor, plasma and concentrate
pp. 2097-2099(3)
Authors: THELWELL, C.; RIGSBY, P.; LONGSTAFF, C.; On behalf of the ISTH‐SSC Subcommittee on Factor XI and the Contact Systemcr4

Favourites:
ADD

Free Content Value assignment of the WHO 6th International Standard for blood coagulation factor VIII and von Willebrand factor in plasma (07/316)
pp. 2100-2102(3)
Authors: HUBBARD, A. R.; HAMILL, M.; BEEHARRY, M.; BEVAN, S. A.; HEATH, A. B.; on behalf of the SSC Sub‐Committees on Factor VIII/Factor IX and von Willebrand factor of ISTHcr6

Favourites:
ADD

Free Content Antiplatelet effects of aspirin vary with level of P2Y
pp. 2103-2105(3)
Authors: KIRKBY, N. S.; LEADBEATER, P. D. M.; CHAN, M. V.; NYLANDER, S.; MITCHELL, J. A.; WARNER, T. D.

Favourites:
ADD
Favourites:
ADD

Free Content The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV‐077 is a more potent inhibitor of platelet function than aspirin
pp. 2109-2111(3)
Authors: FONTANA, P.; ALBERTS, P.; SAKARIASSEN, K. S.; BOUNAMEAUX, H.; MEYER, J.‐P.; SANTANA SORENSEN, A.

Favourites:
ADD

Free Content Effect of 5‐HT
pp. 2112-2115(4)
Authors: BAMPALIS, V. G.; DWIVEDI, S.; SHAI, E.; BRANDL, R.; VARON, D.; SIESS, W.

Favourites:
ADD

Free Content The Simplified Pulmonary Embolism Severity Index (PESI): validation of a clinical prognostic model for pulmonary embolism
pp. 2115-2117(3)
Authors: RIGHINI, M.; ROY, P.‐M.; MEYER, G.; VERSCHUREN, F.; AUJESKY, D.; LE GAL, G.

Favourites:
ADD

Free Content ISTH/SSC lupus anticoagulant testing guidelines: how far have these been adopted by laboratories?
pp. 2117-2119(3)
Authors: JENNINGS, I.; KITCHEN, S.; KITCHEN, D. P.; WOODS, T. A. L.; WALKER, I. D.

Favourites:
ADD

Free Content Association of the C3435T polymorphism of the
pp. 2120-2122(3)
Authors: DE OLIVEIRA ALMEIDA, V. C.; DE SOUZA FERREIRA, A. C.; RIBEIRO, D. D.; GOMES BORGES, K. B.; SALLES MOURA FERNANDES, A. P.; BRUNIALTI GODARD, A. L.

Favourites:
ADD
Favourites:
ADD

Free Content Low‐molecular‐weight‐heparin and pregnancy, when the dose does it: a nephrologist’s opinion: a rebuttal
pp. 2127-2129(3)
Authors: STRATTA, P.; CANAVESE, C.; CENA, T.; QUAGLIA, M.; PERGOLINI, P.; BELLOMO, G.; MAGNANI, C.

Favourites:
ADD

Free Content Low‐molecular‐weight‐heparin and pregnancy, when the dose does it: a nephrologist’s opinion: reply to a rebuttal
pp. 2129-2130(2)
Authors: ROETERS VAN LENNEP, J. E.; MEIJER, E.; KLUMPER, F. J. C. M.; MIDDELDORP, J. M.; BLOEMENKAMP, K. W. M.; MIDDELDORP, S.

Favourites:
ADD

Free Content Join ISTH
pp. 2131-2132(2)

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more